NextFin

ARKK Adjusts Holdings: CRISPR Up by $10M, Tesla Sold Off 5.7M Shares

Summarized by NextFin AI
  • On March 28, 2026, ARK Innovation ETF (ARKK) made significant trading adjustments, reallocating capital among key holdings to respond to market dynamics.
  • Tesla Inc (TSLA) saw a reduction in its position, while CRISPR Therapeutics AG (CRSP) was increased, indicating a shift towards companies with stronger growth potential.
  • Strategic sales of Coinbase and CRCL suggest a pivot due to market sentiment or performance concerns, while increasing CRISPR reflects a bullish outlook on biotech.
  • The overall trading activity indicates ARK's cautious approach in the current market environment, prioritizing liquidity and high-growth opportunities.

ARKK Daily Position Changes Report for March 28, 2026

Overview:

On March 28, 2026, the ARK Innovation ETF (ARKK) experienced notable trading activity, with significant position changes across several key holdings. The fund's strategy appears to be focused on reallocating capital among its top positions, reflecting a response to market dynamics.

Detailed Summary:

The analysis of ARKK's holdings from March 27 to March 28 shows a series of strategic trades. Notably, Tesla Inc (TSLA) saw a reduction in its position, while CRISPR Therapeutics AG (CRSP) was increased. The overall trading activity indicates a shift towards companies perceived as having stronger growth potential or recovering from recent volatility.

Position Changes Table:

Ticker Company Name Direction Shares Traded (estimated) Estimated Trade Value Change ($) % of Portfolio Change
AMD Advanced Micro Devices Inc Buy 4,614,855 $4,614,854.74 +0.2234%
COIN Coinbase Global Inc-A Sell -36,224,370 -$36,224,369.64 -0.4406%
CRCL Sell -59,409,930 -$59,409,930.13 -0.8128%
CRSP CRISPR Therapeutics AG Buy 10,095,543 $10,095,542.88 +0.3884%
HOOD Robinhood Markets Inc-A Sell -4,109,950 -$4,109,949.98 +0.0872%
PLTR Sell -15,844,160 -$15,844,160.48 -0.1323%
ROKU Roku Inc-A Sell -28,209,345 -$28,209,344.93 -0.3277%
SHOP Shopify Inc-A Sell -9,478,663 -$9,478,663.32 +0.0108%
TEM Tempus AI Inc-A Sell -14,931,202 -$14,931,201.54 -0.0714%
TSLA Tesla Inc Sell -5,699,647 -$5,699,646.88 +0.2785%

Analysis and Interpretation:

The decision to sell significant portions of Coinbase and CRCL indicates a strategic pivot, possibly due to market sentiment or performance concerns. The increase in CRISPR Therapeutics suggests a bullish outlook on biotech, aligning with ARK's thematic focus on innovation. The overall reduction in weight for several holdings may reflect a cautious approach in the current market environment, prioritizing liquidity and potential high-growth opportunities.

Weekly Summary (Ending March 27, 2026)

Weekly Recap:

Throughout the week ending March 27, ARKK's trading activity revealed a dynamic reallocation of its investment strategy. The ETF continued to focus on technology and biotech sectors, which are critical to its long-term growth narrative.

Cumulative Analysis:

  • Total Buys: Increased positions in AMD and CRSP.
  • Total Sells: Significant reductions in positions across several holdings, including COIN and ROKU.

Top Weekly Moves:

  1. CRSP: Increased by $10,095,542.88
  2. AMD: Increased by $4,614,854.74
  3. COIN: Decreased by -$36,224,369.64
  4. CRCL: Decreased by -$59,409,930.13
  5. ROKU: Decreased by -$28,209,344.93

Market Context:

The trading week was characterized by volatility in the tech sector, prompting ARK to adjust its holdings to mitigate risk while pursuing growth opportunities. This strategy aligns with ARK's long-term investment philosophy focused on disruptive innovation.

Explore more exclusive insights at nextfin.ai.

Insights

What is the strategy behind ARK Innovation ETF's position changes?

How has the trading activity of ARKK evolved over the past week?

What factors influenced the ETF's decision to sell Coinbase and CRCL?

What recent trends are observed in the biotech sector according to ARK's holdings?

Which companies were the most significantly impacted by ARKK's trades?

What does ARK's focus on technology and biotech indicate about market trends?

How do ARKK's position changes reflect current market dynamics?

What are the potential risks associated with ARKK's investment strategy?

In what ways does ARK's approach differ from traditional investment strategies?

What is the significance of the increased position in CRISPR Therapeutics?

How do ARK's trading patterns compare to those of other ETFs in the same sector?

What challenges does ARK face in maintaining its growth narrative?

What recent updates have occurred in the ARK Innovation ETF's portfolio?

How might ARK's investment strategy evolve in response to market changes?

What lessons can be learned from ARKK's recent trading decisions?

What are the implications of ARK's shift towards higher liquidity holdings?

How do the recent trades align with ARK's long-term investment philosophy?

What role do investor sentiments play in ARK's trading decisions?

Search
NextFinNextFin
NextFin.Al
No Noise, only Signal.
Open App